Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Free Cash Flow (2021 - 2026)

Prokidney's (PROK) quarterly Free Cash Flow came in at -$44.2 million in Q2 2026, down 28.03% year-over-year from -$61.4 million in Q2 2025, and up 2.78% quarter-over-quarter from -$45.5 million in Q1 2026.

Analysis

Prokidney (PROK) Free Cash Flow (2021 - 2026) Analysis & Trends

Prokidney (PROK) has reported Free Cash Flow for 6 consecutive years, with -$44.2 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Free Cash Flow fell 28.03% year-over-year to -$44.2 million in Q2 2026; TTM through Jun 2026 was -$159.7 million, a 8.97% decrease from a year earlier, with the FY2025 full-year figure at -$135.3 million, up 13.18% from the prior year.
  • Free Cash Flow was -$44.2 million for Q2 2026 at Prokidney, up from -$45.5 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$16.1 million in Q4 2022 and troughed at -$51.7 million in Q3 2023.
  • A 5-year average of -$32.4 million and a median of -$31.7 million in 2024 frame the typical range for Free Cash Flow.
  • Across the five-year window, Free Cash Flow sank 11810044.93% in 2022 and soared 38.81% in 2024, its largest moves.
  • Over 5 years, Free Cash Flow stood at -$16.1 million in 2022, then tumbled by 67.77% to -$27.0 million in 2023, then plunged by 84.3% to -$49.7 million in 2024, then grew by 22.98% to -$38.3 million in 2025, then retreated by 15.53% to -$44.2 million in 2026.
  • The last three Free Cash Flow figures came in at -$44.2 million (Q2 2026), -$45.5 million (Q1 2026), and -$38.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 71.22 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - -84.15 Mn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn -66.26 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn -13.40 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn -29.05 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - -68.51 Mn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn -18.20 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn 196.52 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 14.46 Mn
10 Prokidney 346.07 Mn 346.07 Mn - -44.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -44.21 Mn
Mar 31, 2026 -45.47 Mn
Dec 31, 2025 -38.27 Mn
Sep 30, 2025 -31.79 Mn
Jun 30, 2025 -34.53 Mn
Mar 31, 2025 -30.73 Mn
Dec 31, 2024 -49.68 Mn
Sep 30, 2024 -31.65 Mn
Jun 30, 2024 -38.93 Mn
Mar 31, 2024 -35.61 Mn
Dec 31, 2023 -26.96 Mn
Sep 30, 2023 -51.72 Mn
Jun 30, 2023 -18.62 Mn
Mar 31, 2023 -26.98 Mn
Dec 31, 2022 -16.07 Mn
Sep 30, 2022 -23.16 Mn
Jun 30, 2022 -23.41 Mn
Mar 31, 2022 -16.30 Mn
Dec 31, 2021 -1.75 Mn
Sep 30, 2021 -1.14 Mn